Tower Research Capital LLC (Trc) Kodiak Sciences Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.39 Billion
Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,817 shares of KOD stock, worth $54,959. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,817

Previous 6,485 56.56%

Holding current value

$54,959

Previous $24,000 91.67%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$3.68 - $16.37 $13,498 - $60,045	-3,668 Reduced 56.56%	2,817 $46,000
Q2 2025 Aug 14, 2025	BUY	$2.06 - $4.92 $5,821 - $13,903	2,826 Added 77.23%	6,485 $24,000
Q1 2025 May 15, 2025	BUY	$2.81 - $9.57 $5,479 - $18,661	1,950 Added 114.1%	3,659 $10,000
Q4 2024 Feb 13, 2025	SELL	$2.6 - $10.9 $3,679 - $15,423	-1,415 Reduced 45.29%	1,709 $17,000
Q3 2024 Nov 14, 2024	SELL	$2.2 - $3.25 $25,328 - $37,417	-11,513 Reduced 78.66%	3,124 $8,000

Q2 2024 Aug 13, 2024	BUY	$2.29 - $4.48 $27,970 - $54,718	12,214 Added 504.09%	14,637 $34,000
Q1 2024 May 15, 2024	SELL	$3.01 - $7.45 $25,359 - $62,766	-8,425 Reduced 77.66%	2,423 $12,000
Q4 2023 Feb 13, 2024	SELL	$1.4 - $3.24 $8,604 - $19,913	-6,146 Reduced 36.17%	10,848 $32,000
Q3 2023 Nov 14, 2023	BUY	$1.8 - $7.49 $28,188 - $117,293	15,660 Added 1173.91%	16,994 $30,000
Q2 2023 Aug 14, 2023	SELL	$4.3 - $9.48 $69,354 - $152,902	-16,129 Reduced 92.36%	1,334 $9,000
Q1 2023 May 09, 2023	SELL	$4.81 - $8.88 $21,062 - $38,885	-4,379 Reduced 20.05%	17,463 $109,000
Q4 2022 Feb 10, 2023	BUY	$6.52 - $8.05 $33,910 - $41,868	5,201 Added 31.25%	21,842 $156,000
Q3 2022 Nov 10, 2022	BUY	$7.57 - $12.5 $94,329 - $155,762	12,461 Added 298.11%	16,641 $129,000
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.48 $14,137 - $26,591	2,805 Added 204.0%	4,180 $32,000
Q1 2022 May 12, 2022	SELL	$7.09 - $89.45 $16,158 - $203,856	-2,279 Reduced 62.37%	1,375 $11,000
Q4 2021 Feb 14, 2022	BUY	$80.85 - $128.49 $199,780 - $317,498	2,471 Added 208.88%	3,654 $310,000
Q3 2021 Nov 15, 2021	SELL	$81.97 - $106.94 $51,395 - $67,051	-627 Reduced 34.64%	1,183 $113,000
Q2 2021 Aug 16, 2021	SELL	$77.2 - $126.54 $19,608 - $32,141	-254 Reduced 12.31%	1,810 $168,000
Q1 2021 May 17, 2021	BUY	$110.45 - $164.47 $58,648 - $87,333	531 Added 34.64%	2,064 $234,000
Q4 2020 Feb 16, 2021	BUY	$60.78 - $154.03 $13,250 - $33,578	218 Added 16.58%	1,533 $225,000
Q3 2020 Nov 16, 2020	SELL	$45.05 - $59.27 $275,841 - $362,910	-6,123 Reduced 82.32%	1,315 $78,000
Q2 2020 Aug 13, 2020	BUY	$42.74 - $66.25 $317,900 - $492,767	7,438 New	7,438 $403,000
Q4 2019 Feb 07, 2020	SELL	$13.9 - $76.65 $6,866 - $37,865	-494 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$10.24 - $17.57 $4,689 - $8,047	458 Added 1272.22%	494 $7,000
Q2 2019 Aug 13, 2019	SELL	$6.2 - $12.0 $4,947 - $9,576	-798 Reduced 95.68%	36 $0
Q1 2019 May 14, 2019	BUY	$6.43 - $9.44 $5,362 - $7,872	834 New	834 $6,000

Others Institutions Holding KOD

# of Institutions

128

Shares Held

44.4M

Call Options Held

125K

Put Options Held

133K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $1.02B
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Kodiak Sciences Inc. Transaction History